A pre-IND and/or INTERACT meeting with the FDA can be beneficial for many reasons including minimizing costs and unnecessary studies. In this presentation, Dr. Elizabeth Mannick (a technical project lead for the Catalyze program) helps investigators effectively prepare for a pre-IND and INTERACT meeting by clarifying the process from start to finish.
This webinar was presented on September 12th, 2024 to an invited audience.
This video is provided for educational purposes only.